BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17876138)

  • 1. [The third report from Sapporo Tsukisamu Hospital--chemotherapy for patients with advanced gastric cancer (peritoneal dissemination, peritonitis carcinomatosa)].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Yamaguchi K; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1405-11. PubMed ID: 17876138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The first report from Sapporo Tsukisamu Hospital--chemotherapy and chemoradiotherapy for patients with advanced pancreatic cancer].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Koito K; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1059-66. PubMed ID: 17637542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The second report from Sapporo Tsukisamu hospital--chemotherapy for patients with advanced colorectal cancer].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1241-7. PubMed ID: 17687205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The fourth report from Sapporo Tsukisamu Hospital - chemotherapy and its regimen as second choice for patients with early gastric cancer].
    Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Yamaguchi K; Shirasaka T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1589-94. PubMed ID: 17940373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
    Gu Y; Shu Y; Xu Q
    Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
    Kim YH; Yamaguchi K; Bang YJ; Takiuchi H; Kang WK; Sato A; Kang YK; Sakamoto J; Abe C; Sakata Y
    Jpn J Clin Oncol; 2007 Jul; 37(7):501-8. PubMed ID: 17673470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with 5-fluorouracil, cisplatin and paclitaxel for pretreated patients with advanced gastric cancer.
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Anticancer Res; 2007; 27(5B):3535-9. PubMed ID: 17972514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three advanced gastric cancer patients successfully treated by combination therapy of paclitaxel and cisplatin].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Katsuta M; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2007 May; 34(5):769-72. PubMed ID: 17496455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
    Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with intra-perioneal infusion of CDDP and continuous intravenous infusion of 5-FU for peritoneal metastasis in gastric cancer--analysis of long-term survivors].
    Fujiwara H; Terashima M; Takagane A; Abe K; Irinoda T; Yonezawa H; Nakaya T; Oyama K; Takahashi M; Saito K
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2342-5. PubMed ID: 12484070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment for advanced gastric cancer with positive lavage cytology-systemic versus intraperitoneal chemotherapy].
    Iwasaki Y; Ohashi M; Nunobe S; Iwanaga T; Iwagami S; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2009-11. PubMed ID: 19106506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical effect of low-dose FP (5-FU + low-dose CDDP) in patients with far advanced gastric cancer, and their quality of life].
    Murakami S; Yoshida K; Kin R; Nishimoto N; Kagawa Y; Yano Y; Nishiyama M; Hirai T; Toge T
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):853-8. PubMed ID: 10897211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination].
    Ishikawa T; Mizuno K; Togashi T; Watanabe K; Seki K; Ohta H; Yoshida T; Kamimura T
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):469-72. PubMed ID: 15853212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of long-term survival of gastric cancer with peritoneal metastasis effectively treated by TS-1 and paclitaxel (PTX) combination therapy].
    Tanaka K; Kanamaru T; Yamamoto M
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):993-6. PubMed ID: 16835495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
    Popov I; Radosevic-Jelic L; Jezdic S; Milovic M; Borojevic N; Stojanovic S; Stankovic V; Josifovski T; Kezic I
    J BUON; 2008; 13(4):505-11. PubMed ID: 19145671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
    Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
    Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
    Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
    Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
    Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.